Aldo-Benson M A
Cell Immunol. 1986 Sep;101(2):391-402. doi: 10.1016/0008-8749(86)90152-8.
Two continuously growing nonmalignant B-cell lines specific for the hapten DNP have been used to study tolerance in developing B cells. These cell lines have previously been shown to consist of small cells without sIgM but with cytoplasmic mu chains, and mature sIgM- and sIgD-bearing cells. When the sIgM-negative cells are placed in culture, mature DNP-specific B cells begin to appear. The studies reported here have shown that when these cell lines were propagated in the presence of either 200 micrograms/ml or 1 mg/ml of the tolerogen DNP-MGG there was no inhibition of cell line growth as measured by thymidine incorporation, and no inhibition of receptor expression by maturing B cells. The cell line lymphocytes propagated in the presence of 200 micrograms/ml DNP-MGG for 7, 30, 45, or 60 days became tolerant and the tolerance persisted for at least 6 days after removal of DNP-MGG. However, tolerance was lost between 6 and 10 days after removal of DNP-MGG. Propagation of the cell lines for 30 days in either DNP-KLH or DNP-Ficoll produced the same results. Limiting dilution cultures of cell line lymphocytes made tolerant by growing them for 30 days in the presence of DNP-MGG demonstrated that there was a marked decrease in precursor frequency compared to controls. However, cell line lymphocytes made tolerant by a 48-hr incubation with DNP-MGG did not have a significant decrease in precursor frequency. These data suggest that tolerance induced by growing these cell lines in the presence of DNP-MGG is a valid in vitro model of tolerance in developing antigen-specific B cells. Tolerance induced in this model is consistent with the clonal anergy hypothesis, but requires the continued presence of DNP-MGG to maintain unresponsiveness. This suggests that clonal anergy can occur in B cells but may not be the sole mechanism of self tolerance for those antigens which are sequestered from the immune system.
两种针对半抗原二硝基苯(DNP)的持续生长的非恶性B细胞系被用于研究发育中B细胞的耐受性。这些细胞系先前已被证明由无表面免疫球蛋白M(sIgM)但有细胞质μ链的小细胞,以及成熟的带有sIgM和sIgD的细胞组成。当将sIgM阴性细胞置于培养中时,成熟的DNP特异性B细胞开始出现。此处报道的研究表明,当这些细胞系在200微克/毫升或1毫克/毫升的耐受原DNP-马血清球蛋白(DNP-MGG)存在下增殖时,通过胸腺嘧啶核苷掺入法测量,细胞系生长未受抑制,成熟B细胞的受体表达也未受抑制。在200微克/毫升DNP-MGG存在下增殖7、30、45或60天的细胞系淋巴细胞变得耐受,并且在去除DNP-MGG后耐受性持续至少6天。然而,在去除DNP-MGG后6至10天之间耐受性丧失。在DNP-钥孔戚血蓝蛋白(DNP-KLH)或DNP-聚蔗糖(DNP-Ficoll)中使细胞系增殖30天产生了相同的结果。通过在DNP-MGG存在下生长30天而变得耐受的细胞系淋巴细胞的有限稀释培养表明,与对照相比,前体细胞频率显著降低。然而,通过与DNP-MGG孵育48小时而变得耐受的细胞系淋巴细胞的前体细胞频率没有显著降低。这些数据表明,在DNP-MGG存在下生长这些细胞系所诱导的耐受性是发育中抗原特异性B细胞耐受性的一种有效的体外模型。在该模型中诱导的耐受性与克隆失能假说一致,但需要持续存在DNP-MGG以维持无反应性。这表明克隆失能可发生在B细胞中,但可能不是那些与免疫系统隔离的抗原的自身耐受性的唯一机制。